Summary of Market Trends:
The global market for immunosuppressant drugs used in organ transplants experienced substantial growth, with a valuation of USD 5.78 Billion in 2022, projected to reach USD 8.23 Billion by 2032, reflecting a rapid revenue Compound Annual Growth Rate (CAGR) of 4%. Factors driving this growth include the increasing number of organ transplant procedures worldwide, coupled...
English
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian